Intravenous iron isomaltoside 1000 (Monofer®) reduces postoperative anaemia in preoperatively non‐anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double‐blind placebo‐controlled clinical trial (the PROTECT trial)

Publisher: John Wiley & Sons Inc

E-ISSN: 1423-0410|109|3|257-266

ISSN: 0042-9007

Source: VOX SANGUINIS, Vol.109, Iss.3, 2015-10, pp. : 257-266

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract